Oncology News Central Peer-Spectives
Skupno trajanje:
8 h 08 min
Should All Breast Cancer Patients Get T-DXd? "Results of DESTINY-Breast06 Do Suggest That"
Oncology News Central Peer-Spectives
10:46
Oncologist Shortage “Has Gotten to the Crisis Level”
Oncology News Central Peer-Spectives
10:02
“Monster Improvements” in CLL Care Prompt Questions About BTK Inhibitor Use
Oncology News Central Peer-Spectives
09:20
“Better to Have Choices”: How New Data Transform EGFR-Mutated NSCLC Care
Oncology News Central Peer-Spectives
10:34
Practice-Changing Data Introduce “Whole New Challenge” in Prostate Cancer
Oncology News Central Peer-Spectives
11:16
FDA Approval for TIL Therapy “Real Milestone” That Has Been “Long Time Coming”
Oncology News Central Peer-Spectives
11:26
From “Fairytale” to Reality? Paradigm Shift in Bladder Cancer Care
Oncology News Central Peer-Spectives
10:48
FDA Approvals, Pivotal Trial Data Change Approach to Breast Cancer Progression
Oncology News Central Peer-Spectives
11:57
Controversies, Difficult Questions Arise in NSCLC Amid New Data
Oncology News Central Peer-Spectives
10:55
What FDA Approval of Belzutifan Means for Kidney Cancer Care
Oncology News Central Peer-Spectives
10:08
Despite Lack of Head-to-Head Trials, Practice Patterns Shifting in Breast Cancer
Oncology News Central Peer-Spectives
12:04
Which FDA Approvals, Other Advances Changed ER-Positive Breast Cancer Care in 2023?
Oncology News Central Peer-Spectives
10:32
“New Disruptor” in Prostate Cancer: PSMA PET and Other Treatment Advances
Oncology News Central Peer-Spectives
11:30
Practice-Changing Results in Prostate Cancer, as Enzalutamide Regimens Show Strong Benefit
Oncology News Central Peer-Spectives
11:56
ER-Positive Breast Cancer Advances and Other Eagerly Anticipated Data at SABCS 2023
Oncology News Central Peer-Spectives
11:47
Inside ODAC’s Vote on Sotorasib in Advanced and Metastatic NSCLC: Lessons Learned
Oncology News Central Peer-Spectives
13:15
First-Line Osimertinib Plus Chemo in NSCLC: How to Weigh Toxicity vs. Efficacy
Oncology News Central Peer-Spectives
09:15
What Recent “Outstanding Results” in MCL Mean for Practice
Oncology News Central Peer-Spectives
11:13
The Quest to Cure CLL: “Remarkable” Results With New Strategy
Oncology News Central Peer-Spectives
16:00
Which Data From the 2023 World Conference on Lung Cancer Are Most Likely to Change Practice?
Oncology News Central Peer-Spectives
14:18
“Really Impactful” New Guidelines for Stage IV NSCLC With Driver Alterations
Oncology News Central Peer-Spectives
15:07
More “Cage Rattling,” Less Talking: Susan Love’s Lessons for Oncologists
Oncology News Central Peer-Spectives
13:24
Will HER3 Targeting Change Breast Cancer Care?
Oncology News Central Peer-Spectives
12:43
“Practice-Expanding” Data on Adjuvant Osimertinib in NSCLC: Steps to Take Now
Oncology News Central Peer-Spectives
13:36
“Don't Just Throw Drugs Together”: How to Best Approach ESR1 Mutations in Breast Cancer
Oncology News Central Peer-Spectives
13:21
mRNA Cancer Vaccines: When to Expect FDA Approval, and What’s Next?
Oncology News Central Peer-Spectives
11:57
“Major Wins” in Lung Cancer Treatment: How “Explosion of Data” Is Changing Practice
Oncology News Central Peer-Spectives
11:44
“Great Therapies for All-Comers” in CLL: How Can Oncologists “Pick and Choose?”
Oncology News Central Peer-Spectives
14:37
Pragmatica-Lung Tests a Treatment and a New Approach to Trials
Oncology News Central Peer-Spectives
09:51
The Best First Step in Metastatic NSCLC Care
Oncology News Central Peer-Spectives
09:13
Neo- and Adjuvant Treatments Are Changing Care in Early NSCLC
Oncology News Central Peer-Spectives
11:38
NALIRIFOX Changes Care in Pancreatic Cancer: Here’s How
Oncology News Central Peer-Spectives
10:42
Myelofibrosis Remains Tough to Treat, But New Drugs Are Paving the Way
Oncology News Central Peer-Spectives
13:46
KRAS Inhibition in NSCLC: When, How, and Why?
Oncology News Central Peer-Spectives
14:12
Strategies for Navigating a Hematology/Oncology Fellowship
Oncology News Central Peer-Spectives
14:07
Taking Aim at MET and KRAS in NSCLC
Oncology News Central Peer-Spectives
12:15
Mantle Cell Lymphoma: Optimizing Current Therapies
Oncology News Central Peer-Spectives
12:36
COSMIC-313 trial and the Complex Treatment Landscape for Metastatic Renal Cell Cancer: How Do You Decide?
Oncology News Central Peer-Spectives
12:05
Finding Joy in Work: ASCO’s Career Development Resources Help Trainees Choose Their Path
Oncology News Central Peer-Spectives
14:52
Considering an Oncology Fellowship? Listen to This First
Oncology News Central Peer-Spectives
17:54